NCT05860556

Brief Summary

The SENIOR STUDY is aimed at improving the condition of older adults and malnutrition management in and out Italian hospital settings, since malnutrition is highly prevalent, clinically relevant and potentially treatable condition. This study consist of two phases: an initial cross-sectional phase and a secondary nutritional intervention phase (RCT). The SENIOR CROSS-SECTIONAL study aims to map malnutrition status in accordance with the most recent GLIM criteria and investigate the association between malnutrition and anthropometric, demographic and socioeconomic, and lifestyle factors. In addition, sarcopenia will be diagnosed (EWGSOP2 consensus criteria) and blood markers will be measured. Malnutrition in Italian hospital setting is highly prevalent but the current malnutrition data prevalence and the general characteristics of older adults are not updated. Thus, it is expected to find a high malnutrition prevalence and an inadequate nutritional status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
303

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 16, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

November 6, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

2.1 years

First QC Date

April 26, 2023

Last Update Submit

April 30, 2026

Conditions

Keywords

GLIMolder adultsprevalencehospitalnutritionrisk factormalnutritionsarcopeniasustainability

Outcome Measures

Primary Outcomes (1)

  • Prevalence of malnutrition in free-living and hospitalized older adults

    Malnutrition diagnosis (GLIM) with Malnutrition Universal Screening Tool (MUST) screening tool

    Day 1

Secondary Outcomes (23)

  • Prevalence of sarcopenia in free-living and hospitalized older adults

    Day 1

  • Level of physical activity in free-living and hospitalized older adults

    Day 1

  • Activities of daily living

    Day 1

  • Level of adherence to Mediterranean diet in free-living and hospitalized older adults

    Day 1

  • Level of adherence to Mind Diet in free-living and hospitalized older adults

    Day 1

  • +18 more secondary outcomes

Eligibility Criteria

Age65 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Older adults (over 65 years old), free-living or hospitalized, admitted at the hospitals

You may qualify if:

  • Age ≥ 65 years old
  • Admission to U.O. of General Medicine and to U.O.S.D. of Endocrinology and Metabolic diseases of ICS Maugeri IRCCS Hospital; to the Division and Specialist Gastroenterology Clinic of the IRCCS Policlinico San Matteo Foundation, Pavia, Italy; to the Department of Neurology and Geriatrics of the IRCCS San Gerardo dei Tintori Foundation, Monza, Italy
  • Informed consent written and signed

You may not qualify if:

  • Dysphagia
  • Terminal disease
  • History of bariatric surgery
  • Dementia or cognitive decline (MMSE score \<20/30)
  • Eating disorder
  • Patients with tumor diagnosis not in remission and currently not treated with oncological therapy
  • Advanced liver failure (CHILD ≥ B)
  • Advanced renal failure (eGFR \< 15 mL/min/1.73m \^2 )
  • Advanced chronic or acute respiratory failure (pO2 \< 60 mmHg or PCO2 \> 45 mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U.O. of General Medicine and U.O.S.D. of Endocrinology and Metabolic diseases of ICS Maugeri IRCCS Hospital, Pavia

Pavia, PV, 27100, Italy

Location

Related Publications (3)

  • Coperchini F, Greco A, Teliti M, Croce L, Chytiris S, Magri F, Gaetano C, Rotondi M. Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing. Cytokine Growth Factor Rev. 2025 Apr;82:31-42. doi: 10.1016/j.cytogfr.2024.08.004. Epub 2024 Sep 2.

  • Madini N, Vincenti A, Beretta A, Santero S, Viroli G, Cena H. Addressing Inflammaging and Disease-Related Malnutrition: Adequacy of Oral Nutritional Supplements in Clinical Care. Nutrients. 2024 Nov 29;16(23):4141. doi: 10.3390/nu16234141.

  • Viroli G, Santero S, Madini N, Di Sabatino A, Donini LM, Magri F, Zuccotti GV, Calcaterra V, Giannetta E, Lenti MV, Masuelli L, Molfino A, Coperchini F, Daconto L, Di Napoli I, Lepore F, Spaziani M, Spinello Z, Mordà F, Vincenti A, Beretta A, Aronico N, Delliponti M, Mengoli C, Palumbo I, Rossi CM, Cena H. Onfoods spoke 6 projects: Tackling malnutrition. Clinical Nutrition ESPEN 63; 1234-1235. doi: 10.1016/j.clnesp.2024.07.811

    RESULT

Related Links

MeSH Terms

Conditions

MalnutritionSarcopenia

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Hellas Cena, Prof

    Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy; Istituti Clinici Scientifici Maugeri IRCCS, Unit of Clinical Nutrition, Pavia, Italy

    PRINCIPAL INVESTIGATOR
  • Flavia Magri, Prof

    Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy; Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy

    PRINCIPAL INVESTIGATOR
  • Antonio Di Sabatino, Prof

    Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy; First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy

    PRINCIPAL INVESTIGATOR
  • Maria Emilia Paladino, Dr

    Department of Medicine and Surgery, University of Milan-Bicocca, 20900 Monza, Italy; Department of Occupational Health, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pro-Rector for Third Mission; Professor of Dietetics and Clinical Nutrition; Human Nutrition Researcher and Head of the Clinical Nutrition Laboratory

Study Record Dates

First Submitted

April 26, 2023

First Posted

May 16, 2023

Study Start

November 6, 2023

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

May 7, 2026

Record last verified: 2026-04

Locations